Intelligent Bio Solutions (INBS) Free Cash Flow (2020 - 2024)
Intelligent Bio Solutions has reported Free Cash Flow over the past 5 years, most recently at -$2.4 million for Q1 2024.
- Quarterly results put Free Cash Flow at -$2.4 million for Q1 2024, up 2.96% from a year ago — trailing twelve months through Mar 2024 was -$7.2 million (up 15.35% YoY), and the annual figure for FY2023 was -$7.4 million, down 119.69%.
- Free Cash Flow for Q1 2024 was -$2.4 million at Intelligent Bio Solutions, up from -$2.9 million in the prior quarter.
- Over the last five years, Free Cash Flow for INBS hit a ceiling of $194975.0 in Q2 2020 and a floor of -$6.2 million in Q1 2021.
- Median Free Cash Flow over the past 5 years was -$1.7 million (2021), compared with a mean of -$1.7 million.
- Peak annual rise in Free Cash Flow hit 103.1% in 2021, while the deepest fall reached 2717.02% in 2021.
- Intelligent Bio Solutions' Free Cash Flow stood at -$776967.0 in 2020, then tumbled by 83.48% to -$1.4 million in 2021, then tumbled by 67.01% to -$2.4 million in 2022, then dropped by 20.51% to -$2.9 million in 2023, then increased by 14.82% to -$2.4 million in 2024.
- The last three reported values for Free Cash Flow were -$2.4 million (Q1 2024), -$2.9 million (Q4 2023), and -$1.3 million (Q3 2023) per Business Quant data.